Top Markets
Coin of the day
BrainsWay Ltd. BrainsWay Ltd.

BrainsWay Ltd.

BWAY
Rank in Stocks #34051
Established in Jerusalem, Israel, in 2003, BrainsWay Ltd. specializes globally... Established in Jerusalem, Israel, in 2003, BrainsWay Ltd. specializes globally in creating and distributing advanced, non-invasive neurostimulation therapies designed to address a wide array of mental health and neurological conditions. The company's primary innovation is its Deep Transcranial Magnetic Stimulation (dTMS) platform, which offers treatment for disorders including major and anxious depression, obsessive-compulsive disorder, nicotine addiction, bipolar disorder, post-traumatic stress disorder, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's solutions are primarily adopted by psychiatric practitioners, hospitals, and medical centers across the United States, Europe, Israel, and other international markets.
Share Price
$15.79
Last synced: 2026-08-14
Market Cap
$6.34M
Change (1 day)
-2.64%
Change (1 year)
134.28%
Country
IL
Trade BrainsWay Ltd. (BWAY)

Category

P/B ratio for BrainsWay Ltd. (BWAY)
P/B ratio as of 2026 TTM: 0
According to BrainsWay Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for BrainsWay Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors